Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime. Academic Article uri icon

Overview

abstract

  • Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Três Braços, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6/62 (10%), mucosal relapse after cutaneous infection in 2/62 (3%), and mucosal relapse after mucosal disease in 2/17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible.

publication date

  • January 1, 1990

Research

keywords

  • Antiprotozoal Agents
  • Leishmania braziliensis
  • Leishmaniasis
  • Meglumine
  • Organometallic Compounds

Identity

Scopus Document Identifier

  • 0025289021

Digital Object Identifier (DOI)

  • 10.1016/0035-9203(90)90321-5

PubMed ID

  • 2260171

Additional Document Info

volume

  • 84

issue

  • 3